home / stock / bctxf / bctxf news

BCTXF News and Press, BriaCell Therapeutics From 11/17/20

Stock Information
Company Name: BriaCell Therapeutics
Stock Symbol: BCTXF
Market: OTC
Website: briacell.com
Menu
BCTXF BCTXF Quote BCTXF Short BCTXF News BCTXF Articles BCTXF Message Board
Get BCTXF Alerts

News, Short Squeeze, Breakout and More Instantly...
BCTXF - BriaCell Therapeutics Corp. Closes Debt Financing

BERKELEY, Calif., and VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (" BriaCell " or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast ...
BCTXF - BriaCell Announces Collaboration with the National Cancer Institute

BriaCell and National Cancer Institute to collaborate on Bria- OTS ™ , BriaCell’s off-the-shelf personalized immunotherapy, as a treatment for cancer . BERKELEY, Calif., and VANCOUVER, British Columbia, Nov. 10, 2...

BCTXF - BriaCell Breast Cancer Survival Data: 13.3 Months Versus 7.2-9.8 Months

Overall Survival of 13. 3 months in patients , including 14 months in patients with Grade I/II tumors , suggesting clinical benefit; Comparison: 7. 2 -9. 8 months in similar p...

BCTXF - BriaCell to Present Clinical Findings at the 2020 San Antonio Breast Cancer Symposium®, December 9 - 11

BERKELEY, Calif., and VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (" BriaCell " or the "Company") (TSX-V:BCT) (OTCQB:BCTXF ) , a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast...
BCTXF - Note from BriaCell Management - October is Breast Cancer Awareness Month

BERKELEY, Calif., and VANCOUVER, British Columbia, Oct. 01, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (" BriaCell " or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) is a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast can...

BCTXF - BriaCell to Present at the 3rd Annual Biologics World Nordic 2020

BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 15, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced ...

BCTXF - BriaCell Awarded Research Grant from Wiseman Cancer Research Foundation

BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 04, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced ...
BCTXF - BriaCell Therapeutics Corp. Announces Completion of Shares for Debt Issuance

BERKELEY, Calif. and VANCOUVER, British Columbia, Aug. 17, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, announces that...

BCTXF - BriaCell Presents Clinical and Scientific Findings at the Annual Symposium of Society of Surgical Oncology 2020

Preliminary safety and efficacy data are being presented today from the clinical trials of Bria-IMT™ in combination with immune checkpoint (PD-1) inhibitors in advanced breast cancer patients. Clinical responses and disease control—without serious side effects—...

BCTXF - Briacell Therapeutics Corp. Announces Shares for Debt Issuance

BERKELEY, Calif. and VANCOUVER, British Columbia, Aug. 11, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, announces that...
Previous 10 Next 10